Eric Le Goff

Eric Le Goff has worked in the pharmaceutical industry since 2004. Starting as an Analytical Development Technician at Novartis, they then moved up to an Analytical Development Project Leader at the same company. After that, they took a role as a Pharmaceutical Development Project Leader at Guerbet before joining International Drug Development as a Technico-Regulatory Project Leader. In 2010, they moved to Innothera as a CMC Regulatory Project Manager and then to AMRING FRANCE (now NORDIC PHARMA) as a Pharmaceutical Development/CMC and Product Quality Manager in 2013. In 2020, they became the Head of Pharmaceutical Development at OT4B, and most recently, in 2022, they took on the role of CMC Director at dianosic.

Eric Le Goff received their Master in Analytical Chemistry and Quality from Université d'Orléans in 2003, after completing their studies at the University of Montpellier between 1998 and 2002.